Bone Bank Allografts

What Bone Bank Allografts does

Bone Bank Allografts (BBA) is a privately-held tissue bank founded in 1993 in San Antonio, Texas, and operating since 2014 as a wholly-owned subsidiary of Globus Medical, Inc. (NASDAQ: GMED). The company recovers, processes, and distributes sterile human allograft tissues for transplantation under the SteriGraft™ portfolio, used in over 1,000,000 cumulative successful transplants at a current run-rate of 60,000+ allografts per year across the United States and internationally.

Name

Bone Bank Allografts

Legal name

Bone Bank Allografts

Website

https://bonebank.com

Company type

Private

Founded year

1993

Operating status

Operating

Headcount range

11–50 employees

Short description

Bone Bank Allografts is a Texas-based tissue bank that processes and distributes sterile human allograft bone, soft tissue, demineralized bone matrix, and amniotic tissue products under the SteriGraft brand for spine, orthopedic, trauma, and dental surgeons via distributors and direct sales.

Ownership category

akta.pro rank

Product category

Tissue Allografts (Human Bone and Soft Tissue Transplants)

NAICS

Biological Product (except Diagnostic) Manufacturing (325414), Blood and Organ Banks (621991), Surgical Appliance and Supplies Manufacturing (339113)

SIC

Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Biological Products, (No Disgnostic Substances) (2836), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)

akta.pro primary industry

Bone Graft Substitutes & Orthobiologics (Synthetic/Allograft/DBM) (HLAHAEAG)

akta.pro secondary industries

Cell & Tissue Banking (biobanking, cord blood/tissue) (HLAAAGAE), Dental Implant Surgery & Bone Grafting (HLABAEAB), Surgical Stapling, Suturing & Hemostasis (Staplers, Clips, Sealants, Tourniquets) (HLAHADAL)

Keywords

• Human allograft tissues
• Bone graft products
• Demineralized bone matrix
• Amniotic tissue patches
• Tissue transplantation

Headquarters

HQ city

San Antonio

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Others

Revenue model

1. Allograft Tissue Products: Sale of sterile human bone and soft tissue allografts under the SteriGraft™ brand for transplantation surgeries. Products include traditional bone allografts, precision specialty allografts, soft tissue allografts, demineralized bone matrix, and amniotic tissue products. Also offers OEM/private label arrangements for custom designs.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels3 records

Core offering

Bone Bank Allografts (BBA) manufactures and distributes sterile human bone and soft tissue allografts for surgical transplantation under the SteriGraft™ brand, including traditional bone grafts, soft tissue grafts, precision specialty spinal allografts, demineralized bone matrix (DBM), and amniotic tissue patches. The company serves spine, orthopedic, trauma, dental, and maxillofacial surgeons in hospitals, surgery centers, and clinics through direct sales and a global distributor network, applying proprietary GraftShield™ sterilization (validated to SAL 10-6 per ISO 11137-2 Method 1) and GraftCleanse™ processing.

Product overview

Bone Bank Allografts (BBA) is a tissue bank providing a comprehensive portfolio of sterile human allograft tissues under the SteriGraft™ brand, utilized in over 1 million successful transplants since 1993. The product portfolio spans five major categories: (1) Traditional Bone Allografts including cortical cancellous crushed, cancellous crushed, ilium tricortical blocks, cortical-cancellous struts, patella blocks, fibula shafts, and femoral heads for general orthopedic reconstruction; (2) Soft Tissue Allografts including tendons (patellar, Achilles, gracilis, semitendinosus, tibialis anterior/posterior, peroneus longus, plantaris), fascia lata, and pericardium for ligament reconstruction; (3) Precision Specialty Allografts comprising computer-designed spinal spacers including cervical ACF implants, ALIF lordosed implants, PLIF castled implants, and dense cancellous blocks for spinal fusion procedures; (4) Demineralized Bone Matrix Products under SteriSorb™ (sponges, chips, strips, cranial discs) and SteriFuse™ (putty, crunch) brands offering osteoconductive and osteoinductive bone void fillers; and (5) Amniotic Tissue Products including AmnioArmor™ and SteriShield II™ dual layer amnion patches for protective barrier applications. BBA's proprietary GraftShield™ and GraftCleanse™ processing technologies provide validated sterilization to SAL 10(-6) per ISO 11137-2 Method 1. Products are distributed directly to medical facilities and through a global distributor network.

Differentiator

Problem solved

Functional benefit

Brands

• SteriGraft™: Line of validated sterile human bone and soft tissue allografts for transplantation
• GraftShield™
• GraftCleanse™
• SteriSorb™
• SteriFlex™
• SteriFuse™
• SteriShield™
• AmnioArmor™

Products and services

• SteriGraft™ Traditional Bone Allografts Traditional bone allografts including cortical cancellous crushed, cancellous crushed, ilium tricortical blocks, cortical-cancellous struts, patella blocks, fibula shafts, and femoral heads for general orthopedic reconstruction and bone void filling.
• SteriGraft™ Soft Tissue Allografts Sterile soft tissue allografts including hemi patellar tendon, whole patellar tendon, pre-shaped patellar tendon, Achilles tendon with/without bone block, gracilis tendon, semitendinosus tendon, tibialis tendon anterior/posterior, peroneus longus tendon, plantaris tendon, fascia lata, and pericardium for ligament reconstruction and tissue repair.
• SteriGraft™ Precision Specialty Allografts Computer-designed and precision-cut 100% human cortical bone spacers and implants including cervical ACF implants, ACF cortical-cancellous spacers, PLIF castled spinal implants, ALIF lordosed spinal implants, dense cancellous blocks, and unicortical dense cancellous blocks for spinal fusion procedures.
• SteriSorb™ Demineralized Bone Matrix Products Demineralized bone matrix sponge, chips, strips, and cranial disc products made from 100% cancellous bone that is compressible with wicking characteristics for bone void filling in spinal fusion, orthopedic, and dental reconstruction surgeries.
• SteriFuse™ DBM Putty and Crunch Osteoconductive and osteoinductive demineralized bone matrix putty and crunch made from 100% demineralized human bone with cortical cancellous bone chips, gamma irradiated to SAL 10(-6), stored at ambient temperature for bone healing.
• SteriScaf™ HSA Cortical Bone Fibers 100% human cortical bone demineralized fibers providing a high surface area scaffold for bone formation with osteoconductive and osteoinductive potential, gamma irradiated to SAL 10(-6), for orthopedic void filling applications.
• SteriFlex™ Wrappable Allografts 100% cortical bone that can be bent, contoured, rolled, trimmed, molded or sewn while maintaining structure, stability, and osteoconductivity, sterilized with GraftShield™ process for orthopedic, neurologic, dental, trauma, and bone augmentation applications.
• AmnioArmor™ Dual Layer Amnion Patch Dual layer human amniotic membrane patch for protective barrier applications over spinal anterior interbody fusion, craniectomy, or carpal tunnel repair. Contains collagen and growth factors, is biocompatible, and resorbs within the body.
• SteriShield II™ Protective Amnion Patch Dual layer desiccated (air dried) amnion patch that rehydrates within the wound setting, eliminating need for sidedness orientation. Includes single layer option. Stored at room temperature for versatile surgical applications.
• OEM and Private Label Allograft Manufacturing Custom OEM and private label manufacturing service allowing medical manufacturing and distribution companies to receive allografts under their own brand with custom-tailored product designs.

Quantifiable outcome

• Over 1 million successful transplants since 1993
• +2 more outcomes

Segments4 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Six partnerships are on record, tiered core and minor.

• Texas Human Biologics (THB)coreTechnology or IntegrationSister company and primary tissue processing partner. The majority of BBA's allograft tissues are processed by THB at their state-of-the-art processing facility in San Antonio, Texas. THB provides custom equipment design, specialized processing, and sterilization capabilities including ethylene oxide and steam sterilization.
• Organ Procurement OrganizationscoreOthersDonor recovery partners essential to tissue supply chain. BBA works closely with donor organizations to ensure safe and effective medical solutions are brought forward. The medical benefits of tissue allografts would be impossible without the generosity of donors.
• Medical ResearchersminorStrategic or Co-development PartnerCompanies possessing technology and other intellectual property in bone augmentation and regeneration are encouraged to contact BBA about partnership, licensing, design, production, and marketing opportunities.
• Medical Manufacturers and DistributorscoreChannel Partner/ Reseller/ DistributorBBA markets under the SteriGraft™ line and partners with medical manufacturing and distribution companies for contract design, processing, and distribution capabilities. Allografts may be provided under a partner's custom OEM or private label.
• QualtexminorOthersCLIA-certified laboratory providing donor testing services for infectious disease screening.
• Eurofins Donor & Product Testing, IncminorOthersCLIA-certified laboratory (formerly VRL Laboratories) providing donor and product testing services at Dallas, Denver, and Marietta locations.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Stryker: Major orthopedic medical device company with a biologics franchise (including BIO4, bone graft substitutes, and sports medicine allografts) competing with SteriGraft™ products across orthopedic reconstruction and trauma.
• Smith+Nephew: Global medical device company with a sports medicine and biologics portfolio (REGENETEN, BIOINCISE bone graft) competing with BBA's soft tissue allografts and DBM products in orthopedic and sports medicine surgery.
• Integra LifeSciences: Large diversified neurosurgery and orthopedic device company with an orthobiologics portfolio including DBM putty, bone grafts, and regenerative tissue products, providing broader-suite competition to BBA's specialty portfolio.

Direct peers

• MiMedx Group: Publicly traded regenerative medicine company focused on dehydrated human amnion/chorion membrane products (EpiFix, AmnioFix) that directly compete with BBA's AmnioArmor™ and SteriShield II™ amniotic patches across surgical applications.
• AlloSource: Tissue bank specializing in bone, tendon, and skin allografts for sports medicine, spine, and orthopedic surgery, serving the same hospital/surgeon customer base as Bone Bank Allografts.
• LifeNet Health: Non-profit tissue bank offering allograft bone, tendon, dermis, and amniotic membrane products with proprietary processing technologies, directly overlapping with BBA's SteriGraft™ bone, soft tissue, DBM, and amniotic product lines.
• MTF Biologics: Non-profit tissue bank and one of the largest allograft processors in the U.S., supplying bone, soft tissue, and DBM allografts to the same spine, orthopedic, and trauma surgeon customers as Bone Bank Allografts.
• Vivex Biologics: Specialty orthobiologics company focused on tissue-based allografts including DBM putty, amniotic products, and bone graft substitutes, competing head-to-head with SteriFuse™, SteriSorb™, and AmnioArmor™ in spine and orthopedics.
• RTI Surgical (Surgalign): Public tissue-based implant manufacturer offering allograft bone, soft tissue, and synthetic bone graft substitutes for spine, sports medicine, and dental surgery, directly competing with BBA's traditional bone and specialty allograft portfolio.

Emerging players

• Organogenesis: Regenerative medicine company with amniotic membrane and bioactive wound care products (Apligraf, AmnioBand) that increasingly intersect with BBA's amniotic tissue platform in surgical barrier and wound care applications.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/bonebank-allografts
• Xx.com/BBAllografts

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bone Bank Allografts